Explore how AI is redefining pharma compliance, enabling smarter oversight, greater operational resilience, and a future ready regulatory framework built for scale.
What inspectors will actually look for, where most pharma plants will struggle, and how AI can quietly strengthen compliance. As Revised Schedule M moves toward full enforcement, pharmaceutical manufacturers are discovering that many compliance challenges are not new; they are becoming more visible. On paper, most Indian pharma manufacturing plants already have SOPs, logs, validation protocols, […]